Research
_en
15 de Julho de 2022
_en
14 de Julho de 2022_en
14 de Julho de 2022_en
06 de Julho de 2022_en
10 de Junho de 2022_en
18 de Maio de 2022InsCer starts commercial production of a radiopharmaceutical used to diagnose Alzheimer’s disease
On Tuesday (26), the Brain Institute (InsCer) of PUCRS started commercial production of the radiopharmaceutical, Florbetaben (18F), which is used in the differential diagnosis of Alzheimer’s disease. InsCer is a pioneer in producing this product in Brazil. As well as manufacturing this...
26 de Abril de 2022_en
20 de Abril de 2022_en
08 de Abril de 2022Research
_en
07 de Abril de 2022